PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.70%
Negative revenue growth while ADI stands at 1.04%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-0.29%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
4.57%
EBIT growth below 50% of ADI's 25.82%. Michael Burry would suspect deeper competitive or cost structure issues.
-1.29%
Negative operating income growth while ADI is at 25.82%. Joel Greenblatt would press for urgent turnaround measures.
17.55%
Net income growth at 50-75% of ADI's 31.30%. Martin Whitman would question fundamental disadvantages in expenses or demand.
19.84%
EPS growth at 50-75% of ADI's 32.73%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
19.35%
Diluted EPS growth at 50-75% of ADI's 30.91%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
-1.61%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.70%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-0.54%
Dividend reduction while ADI stands at 14.79%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
102.12%
OCF growth above 1.5x ADI's 22.71%. David Dodd would confirm a clear edge in underlying cash generation.
130.43%
FCF growth above 1.5x ADI's 25.13%. David Dodd would verify if the firm’s strategic investments yield superior returns.
22.18%
10Y revenue/share CAGR under 50% of ADI's 59.42%. Michael Burry would suspect a lasting competitive disadvantage.
13.14%
5Y revenue/share CAGR under 50% of ADI's 36.21%. Michael Burry would suspect a significant competitive gap or product weakness.
-4.83%
Negative 3Y CAGR while ADI stands at 6.35%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
303.61%
10Y OCF/share CAGR above 1.5x ADI's 24.68%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
136.80%
5Y OCF/share CAGR above 1.5x ADI's 5.89%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
103.54%
Positive 3Y OCF/share CAGR while ADI is negative. John Neff might see a big short-term edge in operational efficiency.
136.66%
Net income/share CAGR above 1.5x ADI's 29.54% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
123.84%
5Y net income/share CAGR above 1.5x ADI's 10.70%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
41.81%
Below 50% of ADI's 165.21%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
3.34%
Below 50% of ADI's 224.37%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-15.44%
Negative 5Y equity/share growth while ADI is at 98.26%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-22.54%
Negative 3Y equity/share growth while ADI is at 7.80%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
638.34%
10Y dividend/share CAGR above 1.5x ADI's 210.46%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
162.46%
5Y dividend/share CAGR above 1.5x ADI's 55.43%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
79.33%
3Y dividend/share CAGR above 1.5x ADI's 52.10%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-10.64%
Firm’s AR is declining while ADI shows 0.66%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
6.64%
Inventory growth well above ADI's 0.30%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
0.94%
Positive asset growth while ADI is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
0.45%
Positive BV/share change while ADI is negative. John Neff sees a clear edge over a competitor losing equity.
3.76%
Debt growth far above ADI's 1.77%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
0.53%
We increase R&D while ADI cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-3.84%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.